Publication:
Long-Term Disability Trajectories in Primary Progressive MS Patients: A Latent Class Growth Analysis

dc.authorscopusid36545349100
dc.authorscopusid7005179252
dc.authorscopusid7004836896
dc.authorscopusid57190082411
dc.authorscopusid6602085940
dc.authorscopusid57202571257
dc.authorscopusid7005617741
dc.contributor.authorSignori, A.
dc.contributor.authorIzquierdo, G.
dc.contributor.authorLugaresi, A.
dc.contributor.authorHupperts, R.
dc.contributor.authorGrand'Maison, F.
dc.contributor.authorSola, P.
dc.contributor.authorHoráková, D.
dc.date.accessioned2020-06-21T13:11:24Z
dc.date.available2020-06-21T13:11:24Z
dc.date.issued2018
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Signori] A., Department of Health Sciences (DISSAL), Università degli Studi di Genova, Genoa, Italy; [Izquierdo] Guillermo Ayuso, Hospital Universitario Virgen Macarena, Sevilla, Spain; [Lugaresi] Alessandra, Università degli Studi di Bologna, Facoltà di Medicina e Chirurgia, Bologna, BO, Italy, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; [Hupperts] Raymond M.M., Zuyderland, Sittard-Geleen, Limburg, Netherlands; [Grand'Maison] François, Neuro Rive-Sud, Greenfield Park, QC, Canada; [Sola] Patrizia, Nuovo Ospedale Civile Sant'Agostino Estense, Modena, MO, Italy; [Horáková] Dana, Department of Neurology and Center of Clinical Neuroscience, Všeobecná Fakultní Nemocnice v Praze, Prague, Czech Republic; [Kubala Havrdová] Eva Kubala, Department of Neurology and Center of Clinical Neuroscience, Všeobecná Fakultní Nemocnice v Praze, Prague, Czech Republic; [Prat] Alexandre, Hôpital Notre-Dame, Montreal, QC, Canada; [Girard] Marc, Hôpital Notre-Dame, Montreal, QC, Canada; [Duquette] Pierre Pascal, Hôpital Notre-Dame, Montreal, QC, Canada; [Boz] Cavit, Karadeniz Teknik Üniversitesi Tip Fakültesi, Trabzon, Turkey; [Grammond] Pierre, Centre de réadaptation en déficience physique Chaudière-Appalaches, QC, Canada; [Terzi] Murat, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Singhal] Bhim Sen, Bombay Hospital and Medical Research Centre, Mumbai, MH, India; [Alroughani] Raed A., Al-Amiri Hospital, Safat, Kuwait; [Petersen] Thor K., Aarhus Universitetshospital, Aarhus, Midtjylland, Denmark; [Ramo-Tello] Cristina M., Hospital Universitari Germans Trias i Pujol, Badalona, Spain; [Oreja-Guevara] Celia, Hospital Clínico San Carlos, Madrid, Madrid, Spain; [Spitaleri] Daniele Litterio A., Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, AV, Italy; [Shaygannejad] Vahid, Isfahan University of Medical Sciences, Isfahan, Isfahan, Iran; [Butzkueven] Helmut, Box Hill Hospital, Sydney, VIC, Australia, Department of Medicine, Melbourne, VIC, Australia; [Kalincik] Tomas, Department of Medicine, Melbourne, VIC, Australia; [Jokubaitis] Vilija G., Department of Medicine, Melbourne, VIC, Australia; [Slee] Mark, Flinders University, Adelaide, SA, Australia; [Fernández-Bolaños] Ricardo, Hospital Universitario de Valme, Sevilla, Seville, Spain; [Sánchez-Menoyo] José Luis, Hospital de Galdakao, Galdakao, Biscay, Spain; [Pucci] Eugenio, UOC Neurologia, Macerata, Italy; [Granella] Franco, Università di Parma, Parma, PR, Italy; [Lechner-Scott] Jeannette S., The University of Newcastle, Australia, Callaghan, NSW, Australia; [Iuliano] Gerardo, Ospedali Riuniti di Salerno, Salerno, Italy; [Hughes] Stella E., Craigavon Area Hospital, Portadown, Armagh, Northern Ireland, United Kingdom; [Bergamaschi] Roberto, IRCCS Fondazione Mondino, Pavia, PV, Italy; [Taylor] Bruce V.M., Royal Hobart Hospital, Hobart, TS, Australia; [Verheul] Freek A.M., Groene Hart Hospital, Gouda, Netherlands; [Edite Rio] Maria, Sao Joao Hospital, Porto, Porto, Portugal; [Amato] Maria Pia, Department of NEUROFARBA, Università degli Studi di Firenze, Florence, FI, Italy; [Sajedi] Seyed Aidin, Department of Neurology, Golestan University of Medical Sciences, Gorgan, Golestan, Iran; [Majdinasab] Nastaran, Golestan Hospital (AJUMS), Ahvaz, Khuzestan, Iran; [van Pesch] Vincent, Cliniques Universitaires Saint-Luc, Brussels, BRU, Belgium; [Sormani] Maria Pia, Department of Health Sciences (DISSAL), Università degli Studi di Genova, Genoa, Italy; [Trojano] Maria, Department of Basic Medical Sciences, Università degli studi di Bari Aldo Moro, Bari, BA, Italyen_US
dc.description.abstractBackground: Several natural history studies on primary progressive multiple sclerosis (PPMS) patients detected a consistent heterogeneity in the rate of disability accumulation. Objectives: To identify subgroups of PPMS patients with similar longitudinal trajectories of Expanded Disability Status Scale (EDSS) over time. Methods: All PPMS patients collected within the MSBase registry, who had their first EDSS assessment within 5 years from onset, were included in the analysis. Longitudinal EDSS scores were modeled by a latent class mixed model (LCMM), using a nonlinear function of time from onset. LCMM is an advanced statistical approach that models heterogeneity between patients by classifying them into unobserved groups showing similar characteristics. Results: A total of 853 PPMS (51.7% females) from 24 countries with a mean age at onset of 42.4 years (standard deviation (SD): 10.8 years), a median baseline EDSS of 4 (interquartile range (IQR): 2.5–5.5), and 2.4 years of disease duration (SD: 1.5 years) were included. LCMM detected three different subgroups of patients with a mild (n = 143; 16.8%), moderate (n = 378; 44.3%), or severe (n = 332; 38.9%) disability trajectory. The probability of reaching EDSS 6 at 10 years was 0%, 46.4%, and 81.9% respectively. Conclusion: Applying an LCMM modeling approach to long-term EDSS data, it is possible to identify groups of PPMS patients with different prognosis. © 2017, © The Author(s), 2017.en_US
dc.identifier.doi10.1177/1352458517703800
dc.identifier.endpage652en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.issue5en_US
dc.identifier.pmid28382837
dc.identifier.scopus2-s2.0-85032873925
dc.identifier.scopusqualityQ1
dc.identifier.startpage642en_US
dc.identifier.urihttps://doi.org/10.1177/1352458517703800
dc.identifier.volume24en_US
dc.identifier.wosWOS:000432098100013
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherSAGE Publications Ltd info@sagepub.co.uken_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectClinical Trialsen_US
dc.subjectDisabilityen_US
dc.subjectHeterogeneityen_US
dc.subjectLong-Termen_US
dc.subjectPrimary Progressive Multiple Sclerosisen_US
dc.subjectTrajectoriesen_US
dc.titleLong-Term Disability Trajectories in Primary Progressive MS Patients: A Latent Class Growth Analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files